Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:
African American Hub News
 

Back to home » News & Views » Treatment News


 

December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

July 14, 2008

Blood Tests Could Replace Liver Biopsies for Hep C

A series of blood tests was nearly as accurate at predicting the progression of liver damage as liver biopsies in people coinfected with both HIV and hepatitis C virus (HCV), say the authors of a study published in the July 31 issue of AIDS. The high level of accuracy, the authors conclude, may reduce the number of liver biopsies in coinfected patients by 83 percent.

Currently, the gold standard for assessing the progression of liver damage, or fibrosis, caused by HCV infection is a liver biopsy. Unfortunately, biopsies are expensive, can be quite painful and carry the risk of internal bleeding.

To investigate whether a series of blood tests, or markers, may be as accurate as a biopsy, Daniel Suzman, MD, and his colleagues from the National Institutes of Health (NIH) in Bethesda, Maryland, studied 100 blood and biopsy samples from 68 people coinfected with HIV and HCV. Suzman’s team found that an eight-marker system—six blood tests combined with a person’s age and whether or not he or she has used antiretroviral (ARV) HIV therapy—correctly classified the stage of liver damage 88 percent of the time.

Suzman’s team also found that a four-marker system—all blood tests—was statistically equivalent to the eight-marker system. The authors caution, however, that their systems will need to be validated in larger clinical trials before being viewed as a replacement for liver biopsies.

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 1 (of 1 total)    

Charles J Etheridge, Atlanta, 2008-07-16 15:27:55
As one who is coinfected I thought that this was very intresting. As it happens I have an appointment at the Atlanta VA on Friday to be seen by the Advanced Liver Disease Clinic and will print this and take it in with me. I am interested in being treated with VX-950 as soon as it is out of the trials, so I hope that is very soon. For the record I have been infected with HIV for nearly 30 years, but at this time one Atripla per day is keeping me undetectable.

comments 1 - 1 (of 1 total)    


[Go to top]


Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Blogs by African-Americans
Antonia
Felipe
Jeanette
Pinnace
Kate
Ferguson

Read the blogs
Overheard in the Forums
"I'm HIV positive and diabetic (as well as have high cholesterol) and some of my meds specify taking them with 'high fat foods' which I have to do twice a day. I've eaten as healthy as possible, but when it comes to high fat foods, I am in a quandary...about what to eat sometimes..."

from Nutrition & HIV


Join the forums

Real Health Poll
Question: How would you characterize your stress level at work?
Minimally stressful
Moderately stressful
Extremely stressful

Smart + Strong Network
POZ Magazine
POZ Personals
POZ Mentor
POZ ASO Directory
AIDSmeds
Real Health Magazine
TuSalud Magazine
ComboCards
Rx Info Cards
Also visit POZ on...
Facebook

MySpace

YouTube

[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy